PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential

Molecular Carcinogenesis
Federica BrugnoliValeria Bertagnolo

Abstract

Limited oxygen availability plays a critical role in the malignant progression of breast cancer by orchestrating a complex modulation of the gene transcription largely dependent on the tumor phenotype. Invasive breast tumors belonging to different molecular subtypes are characterized by over-expression of PLC-β2, whose amount positively correlates with the malignant evolution of breast neoplasia and supports the invasive potential of breast tumor cells. Here we report that hypoxia modulates the expression of PLC-β2 in breast tumor cells in a phenotype-related manner, since a decrease of the protein was observed in the BT-474 and MCF7 cell lines while an increase was revealed in MDA-MB-231 cells as a consequence of low oxygen availability. Under hypoxia, the down-modulation of PLC-β2 was mainly correlated with the decrease of the EMT marker E-cadherin in the BT-474 cells and with the up-regulation of the stem cell marker CD133 in MCF7 cells. The increase of PLC-β2 induced by low oxygen in MDA-MB-231 cells supports the hypoxia-related reorganization of actin cytoskeleton and sustains invasion capability. In all examined cell lines, but with an opposite role in the ER-positive and ER-negative cells, PLC-β2 was involved in the hypo...Continue Reading

References

Mar 7, 2006·Current Drug Targets·Dale G Nagle, Yu-Dong Zhou
Aug 5, 2006·Molecular Pharmacology·Qingdong Ke, Max Costa
Apr 13, 2007·Carcinogenesis·Valeria BertagnoloSilvano Capitani
Feb 5, 2008·Breast Cancer Research : BCR·Mollie H WrightLyuba Varticovski
Oct 22, 2009·British Journal of Cancer·K LundgrenG Landberg
Apr 5, 2011·Biochemical and Biophysical Research Communications·Kwanghee RyuYoungjoo Lee
Apr 7, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nadine Rohwer, Thorsten Cramer
Jun 8, 2011·Cell and Tissue Research·Valeria BertagnoloSilvano Capitani
Dec 20, 2011·Cancer Treatment Reviews·Pilar ErolesAna Lluch
Jan 10, 2012·Breast Cancer Research : BCR·Luciana P SchwabTiffany N Seagroves
Aug 28, 2012·Trends in Molecular Medicine·Gregg L Semenza
Jan 11, 2013·Journal of Cellular and Molecular Medicine·Murielle Mimeault, Surinder K Batra
Jan 23, 2013·Breast Cancer Research and Treatment·Antoinette HollestelleJohn W M Martens
Jan 24, 2013·International Journal of Oncology·Kristina S LehnusQian An
Mar 28, 2013·ISRN Oncology·Aamir Ahmad
Jul 3, 2013·Experimental Hematology & Oncology·Zhong Li
Jul 13, 2013·Journal of Internal Medicine·H Rundqvist, R S Johnson
Aug 27, 2013·Experimental Cell Research·Alexander M ScherbakovMikhail A Krasil'nikov
Oct 26, 2013·Future Oncology·Daniele M Gilkes, Gregg L Semenza
Dec 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Daniele M GilkesGregg L Semenza
Aug 13, 2014·World Journal of Clinical Oncology·Ozlem Yersal, Sabri Barutca
Dec 3, 2014·Biochimica Et Biophysica Acta·Kazuya Tsujita, Toshiki Itoh
Jan 7, 2015·Journal of Zhejiang University. Science. B·Zhao-Ji LiuHua-Feng Zhang
Jan 8, 2015·Frontiers in Oncology·Stephan Lindsey, Sigrid A Langhans
Feb 24, 2015·Seminars in Nuclear Medicine·Neesha DhaniMichael Milosevic
Apr 11, 2015·Trends in Pharmacological Sciences·Gong Peng, Yang Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.